Clinical Perspectives

Pushing for a Cure: New Treatments for Head and Neck-Endocrine Cancer

Moffitt's Head and Neck-Endocrine Oncology Department discuss new treatments for Head and Neck and Endocrine cancers in this webinar and Q&A session.

Moffitt Women Faculty: By the Numbers

Moffitt Cancer Center's women team members come from different backgrounds and cultures across the globe.

Head and Neck Cancer Vaccine Trial on the Horizon

While there currently are two approved immunotherapy treatments for head and neck cancers, only about 20% of patients respond. Vaccine trials like...

Novel Immunotherapy and Chemotherapy in Patients with Ovarian Cancer

Robert Wenham, MD, MS, FACOG, FACS, a gynecologic oncologist and chair of the Gynecologic Oncology Program at Moffitt Cancer Center, discusses novel...

Meet Our Endoscopic Endonasal and Skull Base Tumor Surgeon

We sat down with Moffitt’s newest faculty member on the Neuro-Oncology team, Dr. Andre Beer Furlan, to learn about his unique skills in endoscopic...

Our Commitment to Your Patients

When you refer a patient to Moffitt, they are connected with a healthcare professional the next day. Immediate attention means less anxiety. Quicker...

Moffitt Study Seeks to Inform Improved Treatment Strategies for Clear Cell Renal Cell Carcinoma

Moffitt Cancer Center researchers launched a study to identify clinical meaningful TIME signatures in ccRCC.

Ethnicity’s Role in Checkpoint Blockade Therapies

At Moffitt Cancer Center, patients have access to checkpoint blockade therapies and other advanced treatment options.

Nationally Recognized Cancer Care Now Available in Wesley Chapel

Satellite locations like this one offer an innovative, hybrid care setting – bridging the gap between typical community private practice and academic...

Nationally Recognized Cancer Care Now Available in Wesley Chapel (1)

Satellite locations like this one offer an innovative, hybrid care setting – bridging the gap between typical community private practice and academic...

Oral Sex Habits and HPV-Related Oropharyngeal Cancer Risk

“Safe sexual practices continue to be an important component of preventative health,” said McMullen. “Fortunately, there is also now a highly...

Advancement in Gynecologic Cancer Treatment Using Immune Checkpoint Inhibitors

CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments

Moffitt researchers are leaders in advancing the field of CAR T therapy and multiple myeloma clinical trials provide patients with exciting new...

The Future of CAR T for Gynecologic Cancers

Dr. Robert Wenham, a gynecologic oncologist and chair of the Gynecologic Oncology Program at Moffitt Cancer Center, answers five questions about the...

Promising CAR T-PSMA Clinical Trial in Patients with Metastatic Castration Resistant Prostate Cancer

Moffitt Cancer Center is opening a multi-center, open-label, Phase 1 clinical trial to identify the dose and regimen of CAR T-PSMA cells that can be...